Lavie Bio

Lavie Bio pertence à Compugen.

Compugen é uma empresa listada sob o símbolo CGEN (IL).

Veja o organograma con seus 10 executivos principais

Biografias mais buscadas da Lavie Bio

• Amit Noam, Chief Executive Officer
• Frederic Beudot, Director
• Sassi Masliah, Board Member

Recentes movimentos de executivos em Compugen

• Michelle Mahler atualmente Vice President of Clinical Development, será promovido a Chief Medical Officer em 1 de mar. de 2024  (Notícia publicada em 16 de fevereiro de 2024).
• Kara Rudy, ingressou na Companhia como Vice President, Marketing  (Notícia publicada em 23 de janeiro de 2024).

Criar um alerta
para seguir os movimentos de executivos da Lavie Bio.

Compugen possui 2.277 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Adaptive Phage Therapeutics (Estados Unidos).

Popular M&A news in Biotecnologia

• Histogen has filed for bankruptcy protection  (publicado em 19 de abril de 2024).
• Bruker has announced the acquisition of NanoString Technologies  (publicado em 18 de abril de 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (publicado em 16 de abril de 2024).

Outros contatos sugeridos na indústria do Biotecnologia

• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics
• Vik Bajaj - Director da Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board da Sensorion

Saiba mais sobre a indústria do Biotecnologia >

Últimos comunicados de imprensa de Lavie Bio

• Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing - Lavie Bio
• Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America - Lavie Bio
• Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide - Lavie Bio
• Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements - Lavie Bio
• Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment YalosTM - Lavie Bio
• Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley - Lavie Bio
• Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results - Lavie Bio
• Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience - Lavie Bio
• Lavie Bio Receives Canadian Regulatory Approval for ThrivusTM, Expanding Global Reach - Lavie Bio
• Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer - Lavie Bio
• View more press releases Close

Redes sociais sobre Lavie Bio

• Lavie Bio na Wikipedia, Google News e Yahoo Finance
• Lavie Bio na LinkedIn, Twitter e YouTube

Contate seus executivos por e-mail agora, incluindo Amit Noam

Ligue para a Lavie Bio em +972 ...

Veja o organograma

Register to receive your alert

Relatório um erro